Joinn Laboratories (China) Co Ltd
Company Profile
Business description
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non-Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Contact
A5 Rongjing East Street
Beijing Economic-Technological Development Area
Beijing100176
CHNT: +86 1067869966
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
2,652
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,770.60 | 25.40 | -0.29% |
CAC 40 | 7,684.68 | 80.43 | -1.04% |
DAX 40 | 23,516.23 | 255.22 | -1.07% |
Dow JONES (US) | 42,197.79 | 769.83 | -1.79% |
FTSE 100 | 8,850.63 | 34.29 | -0.39% |
HKSE | 23,892.56 | 142.82 | -0.59% |
NASDAQ | 19,406.83 | 255.66 | -1.30% |
Nikkei 225 | 37,834.25 | 338.84 | -0.89% |
NZX 50 Index | 12,552.87 | 96.23 | -0.76% |
S&P 500 | 5,976.97 | 68.29 | -1.13% |
S&P/ASX 200 | 8,547.40 | 17.70 | -0.21% |
SSE Composite Index | 3,377.00 | 25.66 | -0.75% |